MAIA Biotechnology Declares Clinical Progress For Novel Anticancer Agent

MAIA Biotechnology Inc, a clinical-stage biopharmaceutical organization creating designated immunotherapies for cancer, declared the highlights and key accomplishments year-to-date, including late clinical advancement for lead up-and-comer THIO...

Sermonix Pharma Bags Chinese Nod of IND application For lasofoxifene

Sermonix Pharmaceuticals LLC, a privately held biopharmaceutical firm developing cutting-edge therapeutics for the treatment of metastatic breast cancers (mBC), announced that China's National Medical Products Administration (NMPA) has approved...

Dept of Health Abu Dhabi and MSD Team up For Advance Clinical Research

During the BIO International Convention 2024 in San Diego, USA, the Department of Health – Abu Dhabi (DoH), the healthcare industry's regulator, and MSD, a top biopharmaceutical company, signed a Memorandum of Understanding (MoU). DoH and MSD...

Halozyme Secures European Patent For Enhanze Drug Delivery Platform

Halozyme Therapeutics, Inc, a biopharmaceutical firm, recently made the announcement that it had been granted European Patent No. 4269578. This patent covers the Enhanze rHuPH20 product that is made using Halozyme's Enhanze manufacturing methods...

Dept of Health Abu Dhabi and Opus Genetics Partner For Gene Therapy Research

Opus Genetics, a patient-first, clinical-stage gene therapy company developing treatments for inherited retinal diseases, and the Department of Health – Abu Dhabi (DoH), the Emirate's regulator of the healthcare sector, signed a Memorandum of...

AVS Bags IDE NOD From FDA For Pivotal Intravascular Lithotripsy Study

Amplitude Vascular Systems (AVS), a medical device company focused on the safe and effective treatment of severely calcified arterial disease, declared that it has received an investigational device exemption (IDE) from the United States Food and...

© 2024 India Pharma Outlook. All Rights Reserved.